Using chemical reactions to synthesize complex protein drugs could help researchers create more effective medicines.
IBM researchers have developed a new polymer-like material to treat fungal infections.
A new brain-imaging technology may reveal the true risk of repetitive head injury in contact sports.
Delivering healthy bacteria in a pill could help patients harboring out-of-balance microbial communities.
A Boston startup wants to create precise genome-editing treatments that can address more types of disease than previous gene therapy methods.
A Kansas City hospital is pioneering genomic testing to solve life-threatening mysteries involving infants and kids with developmental disorders.
Genomic technology could accelerate patient trials of new cancer drugs that are targeted to a tumor’s individual molecular profile.
A method for single-cell DNA analysis could provide a safer genetic screen for IVF.
Computer-controlled sedation could lighten the load for intensive-care staff and make the process safer for patients.
A startup will sift through “treasure troves” of data from failed trials to find abandoned Alzheimer’s drugs that might work for some patients.